Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ECF | 9.46 | 0.03 | +0.32% |
| Ellsworth Growth and Income Fund Ltd | |||
| HYXU | 51.73 | 0.15 | +0.28% |
| iShares International High Yield Bd ETF | |||
| IDU | 103.21 | 0.15 | +0.15% |
| iShares US Utilities ETF | |||
| FCFY | 22.42 | N/A | N/A |
| First Trust S&P 500 Div Fr CA Flw ETF | |||
| GBAB | 15.24 | -0.01 | -0.07% |
| Guggenheim Taxable Municipal | |||
A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.
| Ticker / NAME | Correlation To INNMF | 1D Price Change % | ||
|---|---|---|---|---|
| INNMF | 100% | -17.41% | ||
| BIVI - INNMF | 26% Poorly correlated | +13.89% | ||
| HOFBF - INNMF | 23% Poorly correlated | N/A | ||
| CYTK - INNMF | 23% Poorly correlated | -1.69% | ||
| PHRRF - INNMF | 20% Poorly correlated | -3.02% | ||
| IVEVF - INNMF | 15% Poorly correlated | N/A | ||
More | ||||